# PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREV

> **NIH NIH N01** · IIT RESEARCH INSTITUTE · 2022 · $291,405

## Abstract

PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF PROSTATE CANCER

## Key facts

- **NIH application ID:** 10598444
- **Project number:** 75N91019D00012-P00003-759102000001-1
- **Recipient organization:** IIT RESEARCH INSTITUTE
- **Principal Investigator:** DAVID MCCORMICK
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $291,405
- **Award type:** —
- **Project period:** 2020-09-08 → 2023-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10598444

## Citation

> US National Institutes of Health, RePORTER application 10598444, PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREV (75N91019D00012-P00003-759102000001-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10598444. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*